Cargando…
Ablation rate after radioactive iodine therapy in patients with differentiated thyroid cancer at intermediate or high risk of recurrence: a systematic review and a meta-analysis
PURPOSE: We performed a systematic review and a meta-analysis to investigate the successful ablation rate after radioiodine (RAI) administration in patients with differentiated thyroid cancer (DTC) at intermediate-high risk of recurrence. METHODS: A comprehensive literature search of the PubMed, Sco...
Autores principales: | Klain, Michele, Nappi, Carmela, Zampella, Emilia, Cantoni, Valeria, Green, Roberta, Piscopo, Leandra, Volpe, Fabio, Manganelli, Mariarosaria, Caiazzo, Elisa, Petretta, Mario, Schlumberger, Martin, Cuocolo, Alberto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8566414/ https://www.ncbi.nlm.nih.gov/pubmed/34142215 http://dx.doi.org/10.1007/s00259-021-05440-x |
Ejemplares similares
-
Prognostic value of 12-month response to therapy in pediatric patients with differentiated thyroid cancer
por: Zampella, Emilia, et al.
Publicado: (2023) -
Management of differentiated thyroid cancer through nuclear medicine facilities during Covid-19 emergency: the telemedicine challenge
por: Klain, Michele, et al.
Publicado: (2020) -
Whole-Body Radioiodine Effective Half-Life in Patients with Differentiated Thyroid Cancer
por: Klain, Michele, et al.
Publicado: (2021) -
Long-Term Prognostic Value of the Response to Therapy Assessed by Laboratory and Imaging Findings in Patients with Differentiated Thyroid Cancer
por: Klain, Michele, et al.
Publicado: (2021) -
Second Primary Malignancies in Patients with Differentiated Thyroid Cancer after Radionuclide Therapy: A Retrospective Single-Centre Study
por: Piscopo, Leandra, et al.
Publicado: (2022)